For: | Mathew S, Abdel-Hafiz H, Raza A, Fatima K, Qadri I. Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma. World J Hepatol 2016; 8(10): 485-498 [PMID: 27057306 DOI: 10.4254/wjh.v8.i10.485] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v8/i10/485.htm |
Number | Citing Articles |
1 |
Solomon O. Rotimi, Oluwakemi A. Rotimi, Bodour Salhia. Authorship Patterns in Cancer Genomics Publications Across Africa. JCO Global Oncology 2021; (7): 747 doi: 10.1200/GO.20.00552
|
2 |
Hussein Mukasa Kafeero, Dorothy Ndagire, Ponsiano Ocama, Abdul Walusansa, Hakim Sendagire. Tumor Necrosis Factor-α-863C/A and 1031 T/C Single nucleotide polymorphic sites (SNPs) may be putative markers of HBV disease prognosis among Caucasoids: Evidence from a systematic review with meta-analysis. Gene Reports 2022; 26: 101486 doi: 10.1016/j.genrep.2021.101486
|
3 |
Xuemei Li, Huihui Wang, Tao Li, Lianzi Wang, Xian Wu, Jiaqing Liu, Yuanhong Xu, Wei Wei. Circulating tumor DNA/circulating tumor cells and the applicability in different causes induced hepatocellular carcinoma. Current Problems in Cancer 2020; 44(2): 100516 doi: 10.1016/j.currproblcancer.2019.100516
|
4 |
Citrawati Dyah Kencono Wungu, Mochamad Amin, S. Eriaty N. Ruslan, Priyo Purwono, Ulfa Kholili, Ummi Maimunah, Poernomo Setiawan, Maria Lusida, Soetjipto Soetjipto, Retno Handajani. Association between host TNF‑α, TGF‑β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV‑associated chronic liver disease in Indonesian patients. Biomedical Reports 2019; doi: 10.3892/br.2019.1239
|
5 |
Sonam Sahu, Nimisha Paul, Ankit Ganeshpurkar, Nazneen Dubey, Aditya Ganeshpurkar. Catechin ameliorates hepatocellular damage caused by coadministration of isoniazid and rifampicin. Advances in Redox Research 2024; 12: 100107 doi: 10.1016/j.arres.2024.100107
|
6 |
Shuchi Pandya, Misbahuddin Syed, Manuel Castro, Jamie P. Morano, Beata Casanas. Global Virology II - HIV and NeuroAIDS. 2017; : 625 doi: 10.1007/978-1-4939-7290-6_24
|
7 |
Association between five types of Tumor Necrosis Factor-α gene polymorphism and hepatocellular carcinoma risk: a meta-analysis. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07606-6
|
8 |
Citrawati Dyah Kencono Wungu, Mochamad Amin, S. Eriaty N. Ruslan, Priyo Budi Purwono, Ulfa Kholili, Ummi Maimunah, Poernomo Boedi Setiawan, Maria Inge Lusida, Soetjipto Soetjipto, Retno Handajani. DETECTION OF TUMOR NECROSIS FACTOR- (TNF- ) GENE PROMOTERS POLYMORPHISM AMONG LIVER CIRRHOSIS PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION IN SURABAYA, INDONESIA. Indonesian Journal of Tropical and Infectious Disease 2019; 7(5): 115 doi: 10.20473/ijtid.v7i5.7275
|
9 |
Fengxue Yu, Xiaolin Zhang, Suzhai Tian, Lianxia Geng, Weili Xu, Ning Ma, Mingbang Wang, Yuan Jia, Xuechen Liu, Junji Ma, Yuan Quan, Chaojun Zhang, Lina Guo, Wenting An, Dianwu Liu. Comprehensive investigation of cytokine- and immune-related gene variants in HBV-associated hepatocellular carcinoma patients. Bioscience Reports 2017; 37(6) doi: 10.1042/BSR20171263
|
10 |
Hawraa Allawi Luaibi, Bushra Jasim Mohammed. Does TNF-α 308 G/A (rs1800629) gene polymorphism associate with liver and pancreas disorders in Iraqi adults with beta thalassemia major?. Human Antibodies 2024; 31(4): 99 doi: 10.3233/HAB-230015
|
11 |
Aitor Nogales, Marta L. DeDiego. Host Single Nucleotide Polymorphisms Modulating Influenza A Virus Disease in Humans. Pathogens 2019; 8(4): 168 doi: 10.3390/pathogens8040168
|
12 |
Hussein Mukasa Kafeero, Dorothy Ndagire, Ponsiano Ocama, Charles Drago Kato, David Patrick Kateete, Abdul Walusansa, Ali Kudamba, Kigozi Edgar, Fred Ashaba Katabazi, Maria Magdalene Namaganda, Jamilu E. Ssenku, Eddie Wampande, Henry Kajumbula, Hakim Sendagire. The 863C>A and 1031T>C Single Nucleotide Polymorphisms (SNPs) in the Tumor Necrosis Factor Alpha (TNF-α) Promoter Gene May Not Be Putative Predictors of HBV Endemicity. Livers 2023; 3(4): 545 doi: 10.3390/livers3040037
|
13 |
Yan Li, Yuanyuan Zheng, Liwei Wu, Jingjing Li, Jie Ji, Qiang Yu, Weiqi Dai, Jiao Feng, Jianye Wu, Chuanyong Guo. Current status of ctDNA in precision oncology for hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-01940-8
|